iShares Genomics Immunology and Healthcare ETF (IDNA)

Assets	$128.85M
Expense Ratio	0.47%
PE Ratio	2.15
Shares Out	5.85M
Dividend (ttm)	$0.24
Dividend Yield	1.08%
Ex-Dividend Date	Dec 20, 2023
Payout Ratio	2.33%
1-Year Return	-6.94%

Volume	12,458
Open	22.32
Previous Close	22.27
Day's Range	22.05 - 22.35
52-Week Low	17.33
52-Week High	25.52
Beta	1.06
Holdings	63
Inception Date	Jun 11, 2019

About IDNA

Fund Home Page

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: IDNA
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

44.60% of assets

Name	Symbol	Weight
Revolution Medicines, Inc.	RVMD	5.72%
Sarepta Therapeutics, Inc.	SRPT	5.33%
Moderna, Inc.	MRNA	5.04%
Merck & Co., Inc.	MRK	4.72%
GSK PLC	GSK.L	4.29%
Regeneron Pharmaceuticals, Inc.	REGN	4.25%
Exelixis, Inc.	EXEL	4.01%
Sanofi SA	SAN.PA	3.89%
Incyte Corporation	INCY	3.70%
Takeda Pharmaceutical Co Ltd	4502.T	3.63%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2023	$0.16925	Dec 27, 2023
Jun 7, 2023	$0.07077	Jun 13, 2023
Jun 9, 2022	$0.1359	Jun 15, 2022
Dec 13, 2021	$0.25636	Dec 17, 2021
Jun 10, 2021	$0.05215	Jun 16, 2021
Dec 14, 2020	$0.03621	Dec 18, 2020